Case T-524/23: Judgment of the General Court of 13 November 2024 – Boehringer Ingelheim Pharma v EUIPO – Glenmark Pharmaceuticals Europe (Shape of inhaler) (EU trade mark – Invalidity proceedings – Three-dimensional EU trade mark – Shape of an inhaler – Absolute ground for invalidity – Sign which consists exclusively of the shape of goods which is necessary to obtain a technical result – Article 7(1)(e)(ii) and Article 51(1)(a) of Regulation (EC) No 40/94 (now Article 7(1)(e)(ii) and Article 59(1)(a) of Regulation (EU) 2017/1001) – Obligation to state reasons – Article 94(1) of Regulation 2017/1001)